Mr. Barry Balfe
Mr. Barry Balfe was appointed Chief Executive Officer of ICON plc in October 2025 and appointed to the Board of ICON plc in September 2025.
Prior to his role as CEO he served as Chief Operating Officer from January 2025, having previously served as President of ICON Pharma Development Solutions. Mr. Balfe has been with ICON for over 20 years and has held a number of leadership roles across both full service and functional solutions at ICON where he has successfully grown business and has developed and led a number of new strategic partnerships with some of the world's largest pharmaceutical companies. Earlier roles have included EVP, Global Business Development. As part of the FSP leadership team, Mr. Balfe served as Senior Vice-President, Global Program Management where he oversaw operational design, planning & delivery within the resourcing & FSP businesses. Mr. Balfe began his career at ICON in Business Development in 2003, later leading the US FSP business and subsequently European FSP operations.
He holds a Bachelor of Science degree in Chemistry from Dublin City University and Ecole Nationale Supérieure de Chimie de Toulouse, and has completed postgraduate studies in pharmacoepidemiology and pharmacovigilance at London School of Hygiene and Tropical Medicine, University of London.